B-type natriuretic peptide and serum unbound free fatty acid levels after contemporary percutaneous coronary intervention

Journal of Invasive Cardiology

Volumn 20, Issue 4, 2008, Pages 186-188

  Cantor, Warren J ^a   Kim, Hahn Hoe ^b   Jolly, Sanjit ^c   Moe, Gordon ^c   Burstein, Jason M ^d   Mendelsohn, Aurora ^e   Kleinfeld, Alan M ^f   Fitchett, David ^c  

^a SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^b St Mary's General Hospital   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d Rouge Valley Health System   (Canada)

^e CANADIAN HEART RESEARCH CENTRE   (Canada)

^f TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

B natriuretic peptide; Coronary angioplasty; Free fatty acid

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CORONARY STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN ANALYSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS;

EID: 41849106138     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Valle R, Aspromonte N, Feola M, et al. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 2005;11:498-503.
2. Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-3212.
3. Kragelund C, Gronning B, Kober L et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-675.
4. Apple FS, Kleinfeld AM, Adams J. Unbound free fatty acid concentrations are increased in cardiac ischemia. Clinical Proteomics 2004;1:41-44.
5. Kleinfeld AM, Prothro D, Brown DL, et al. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol 1996;78:1350-1354.
6. Kyriakides ZS, Markianos M, Michalis L, et al. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 2000;23:285-288.
7. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000;23:776-780.
8. Lapointe N, Nguyen QT, Desjardins JF, et al. Effects of pre-, peri-, and postmyocardial infarction treatment with omapatrilat in rats: Survival, arrhythmias, ventricular function, and remodeling. Am J Physiol Heart Circ Physiol 2003;285:H398-H405.
9. Richieri GV, Ogata RT, Kleinfeld AM. The measurement of free fatty acid concentration with the fluorescent probe ADIFAB: A practical guide for the use of the ADIFAB probe. Mol Cell Biochem 1999;192:87-94.
10. Bonaca MP, Wiviott SD, Sabatine MS, et al. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol 2007;99:344-348.
11. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 2004;341:41-48.
12. Lainchbury JG, Campbell E, Frampton CM, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735.
13. Fonseca C, Sarmento PM, Minez A, et al. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Rev Port Cardiol 2004;23:979-991.
14. de Vries JE, Vork MM, Roemen TH et al. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997;38:1384-1394.
15. Kleinfeld A, Kleinfeld K, Adams J. Serum levels of unbound free fatty acids reveal high sensitivity for early detection of acute myocardial infarction in patients samples from the TIMI II trial. J Am Coll Cardiol 2002;39:312A.